수술 중 영상 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Intraoperative Imaging Market Size, Share & Trends Analysis Report By Product (iCT, Intraoperative Ultrasound, iMRI, C-arms), By Application (Neurosurgery, Orthopedic Surgery, ENT Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,609,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,950 ￦ 10,055,000

Printable PDF (5-User License)

PDF 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,950 ￦ 12,949,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

수술 중 영상 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 수술 중 영상 시장 규모는 2025-2030년에 걸쳐 CAGR 6.8%를 기록하며, 2030년에는 54억 1,000만 달러에 달할 것으로 예측되고 있습니다.

세계의 만성 질환 증가와 노인 증가가 시장을 견인하고 있습니다. 또한, 기술의 진보와 함께 저침습 수술의 채용이 증가하고 있는 것도 시장 성장에 영향을 주고 있는 요인입니다.

수술 중 영상은 수술 중 실시간 이미지를 제공하는 매우 효율적인 장치이며, 외과 의사가 비정상적인 조직을 발견하고보다 정확하게 수술하는 데 도움이 됩니다. 현재, 수술의 대부분은 근육과 건강한 조직을 보호하기 위해 저침습적인 수법으로 행해지고 있어, 이것을 가능한 한 효과적으로 실시하기 위해서, 수술 정밀도를 평가하기 위해서 다양한 유형의 수술중 이미징 시스템이 채용되는 경우가 많습니다.

암, 뇌졸중, 신경질환, 정형외과, 심혈관질환 등 수술적 개입을 필요로 하는 만성질환의 유병률 상승은 예측기간 동안 시장을 확대할 것으로 예상됩니다. WHO에 따르면 암은 전 세계 주요 사망 원인으로, 2020년에 약 1,000만 명이 사망할 것으로 예상됩니다. 같은 자료에 따르면 암의 30-50%는 위험 요인을 피하고 증거 기반 예방 전략을 실행함으로써 예방할 수 있다고 합니다.

이 시장의 저명한 경쟁업체는 제품 포트폴리오를 확대하고 제조능력을 강화하기 위해 중견/중소기업 인수 및 자금조달 등 다양한 대처를 실시했습니다.

수술 중 영상 시장 보고서 하이라이트

• C-arms 부문이 시장을 독점해 2024년에는 31.1%의 최대 수익 점유율을 차지했습니다.
• 신경 외과 부문은 2024년에 약 30.8%의 최대 수익 점유율을 차지했습니다.
• 병원 부문은 시장을 독점하고 2024년에는 39.1%의 최대 수익 점유율을 차지했으며 예측 기간 동안에도 그 우위성이 계속될 것으로 예상됩니다.
• 북미의 수술 중 영상 시장은 2024년에 34.6%의 가장 큰 매출 점유율을 차지했으며, 이 지역에 상당한 수의 시장 참여자가 존재하고 신제품 개발, 인수 투자 및 R&D 활동에 대한 지속적인 노력으로 인해 간편한 운영을 지원하고 진정한 의료용 이미징 시스템의 가용성을 보장하여 시장 성장을 촉진할 것으로 예상됩니다.
• 아시아태평양에서는 선진적인 이미징 기기에 대한 요구가 높아지고 있기 때문에 수술 중 영상 시장은 예측 기간 중에 가장 빠른 CAGR을 나타낼 것으로 예측되고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 수술 중 영상 시장 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 수술 중 영상 시장 분석 도구
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 수술 중 영상 시장 : 제품별, 추정·동향 분석

• 제품 시장 점유율(2024년, 2030년)
• 부문 대시보드
• 제품에 의한 세계의 수술 중 영상 시장 전망
• 시장 규모, 예측, 동향 분석(2018-2030년)
  • ICT
  • 수술 중 초음파
  • iMRI
  • C-arms

제5장 수술 중 영상 시장 : 용도별, 추정·동향 분석

• 용도 시장 점유율(2024년, 2030년)
• 부문 대시보드
• 용도에 의한 세계의 수술 중 영상 시장 전망
• 시장 규모, 예측, 동향 분석(2018-2030년)
  • 신경외과
  • 심혈관 수술
  • 정형외과
  • 외상/응급실 수술
  • 이비인후과 수술
  • 종양학 수술
  • 기타

제6장 수술 중 영상 시장 : 최종 용도별, 추정·동향 분석

• 최종 용도 시장 점유율(2024년, 2030년)
• 부문 대시보드
• 최종 용도에 의한 세계의 수술 중 영상 시장 전망
• 시장 규모, 예측, 동향 분석(2018-2030년)
  • 병원
  • 전문 클리닉
  • 외래수술센터(ASC)
  • 기타

제7장 수술 중 영상 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석(2024년, 2030년)
• 지역별 시장 대시보드
• 세계의 지역 시장 현황
• 시장 규모, 예측 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
• 공급업체 상황
  • 주요 기업의 시장 점유율 분석(2024년)
  • GE HealthCare
  • Siemens Healthineers
  • Koninklijke Philips NV
  • Medtronic plc
  • Canon Medical Systems Corporation
  • Shimadzu Corporation(Medical Systems)
  • Brainlab AG
  • Ziehm Imaging GmbH
  • IMRIS
  • NeuroLogica Corp.

KTH

영문 목차

영문목차

Intraoperative Imaging Market Growth & Trends:

The global intraoperative imaging market size is expected to reach USD 5.41 billion by 2030, registering a CAGR of 6.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rise in the number of chronic disorders worldwide and the growing number of geriatric populations are driving the market. Additionally, the increase in the adoption of minimally invasive surgeries coupled with technological advancements are factors influencing the market growth.

Intraoperative imaging is a highly efficient device that provides real-time images during surgery, helping surgeons to discover abnormal tissues and operate more precisely. Furthermore, the use of intraoperative devices has aided healthcare facilities in reducing the expense of repeat surgeries, thus lowering the overall financial load on patients. The majority of surgeries are now performed using minimally invasive techniques to protect muscle and healthy tissues, different types of intraoperative imaging systems are often employed to evaluate surgical precision to do this as effectively as possible.

The rising prevalence of chronic diseases like cancer, stroke, neurological conditions, orthopedics, and cardiovascular diseases, which require surgical interventions, is expected to expand the market during the forecast period. As per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The same source stated that between 30 and 50% of cancers can be prevented by avoiding risk factors and implementing evidence-based prevention strategies.

The market's prominent competitors are taking different initiatives, such as the acquisition and funding of medium and small-sized businesses, to expand their product portfolio and enhance their manufacturing capacity. For instance, In July 2020, C-arm developer Ziehm acquired Therenva, a French-based developer of planning and imaging software solutions for cardiovascular procedures.

Intraoperative Imaging Market Report Highlights:

• The C-arm segment dominated the market and accounted for the largest revenue share of 31.1% in 2024. The iMRI segment is expected to grow at the fastest rate of 7.4% CAGR over the forecast period.
• The neurosurgery in application segment accounted for the largest revenue share of about 30.8% in 2024. The orthopedic surgery segment is expected to grow at a CAGR of 7.6% during the forecast period.
• The hospital segment dominated the market and accounted for the largest revenue share of 39.1% in 2024 and is expected to continue its dominance during the forecast period. The ambulatory surgical centers segment is expected to grow at a fastest rate of 6.9% CAGR over the forecast period 2025 to 2030
• North America intraoperative imaging market held the largest revenue share of 34.6% in 2024, as there is a presence of a significant number of market players in the region and their constant efforts in developing new products, investing in acquisitions, and R&D activities to support easy operations and ensure the availability of authentic medical-grade imaging systems is expected to boost the market growth.
• In Asia Pacific, the market for intraoperative imaging is estimated to witness the fastest CAGR during the forecast period, due to the growing need for advanced imaging equipment in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Intraoperative Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for minimally invasive surgeries
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Increase in the prevalence of chronic disorders
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of intraoperative imaging system
    • 3.2.2.2. Increase in adoption of refurbished systems
• 3.3. Intraoperative Imaging Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Intraoperative Imaging Market: Product Estimates & Trend Analysis

• 4.1. Modality Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Intraoperative Imaging Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. iCT
    • 4.4.1.1. iCT market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Intraoperative ultrasound
    • 4.4.2.1. Intraoperative ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. iMRI
    • 4.4.3.1. iMRI market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. C-arms
    • 4.4.4.1. C-arms market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Intraoperative Imaging Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Intraoperative Imaging Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Neurosurgery
    • 5.4.1.1. Neurosurgery market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Cardiovascular surgery
    • 5.4.2.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Orthopedic surgery
    • 5.4.3.1. Orthopedic surgery market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Trauma /emergency room surgery
    • 5.4.4.1. Trauma/emergency room surgery market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. ENT surgery
    • 5.4.5.1. ENT surgery market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Oncology surgery
    • 5.4.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Others
    • 5.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Intraoperative Imaging Market: End-use Estimates & Trend Analysis

• 6.1. End-use Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Intraoperative Imaging Market by End-use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Hospitals
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Specialty clinics
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Ambulatory surgical centers
    • 6.4.3.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Others
    • 6.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Intraoperative Imaging Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key customers
  • 8.3.2. Key company market share analysis, 2024
  • 8.3.3. GE HealthCare
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Siemens Healthineers
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Koninklijke Philips N.V.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Medtronic plc
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Canon Medical Systems Corporation
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Shimadzu Corporation (Medical Systems)
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Brainlab AG
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Ziehm Imaging GmbH
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. IMRIS
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. NeuroLogica Corp.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives

관련자료